XML 80 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Investments in Other Entities — Summarized Balance Sheets and Statements of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Assets                        
Cash and cash equivalents $ 288,027       $ 233,097       $ 288,027 $ 233,097 $ 193,470  
Receivables, net 49,631       10,608       49,631 10,608    
Loans receivable 996       0       996 0    
Total assets 966,213 [1] $ 954,896 $ 967,432 $ 922,659 867,361 [1] $ 871,154 $ 895,717 $ 843,141 966,213 [1] 867,361 [1]    
Liabilities and stockholders’ deficit                        
Current liabilities 148,610     155,542 114,719 115,173 125,873 122,553 148,610 114,719    
Stockholders’ deficit 544,310       454,107       544,310 454,107 329,463 $ 192,335
Total liabilities, mezzanine equity, and stockholders’ equity 966,213       867,361       966,213 867,361    
Statements of Operations                        
Revenues 294,208 317,001 269,697 263,258 195,100 227,117 175,638 176,058 1,144,163 773,915 687,180  
Expenses 281,628 266,910 254,315 237,047 192,852 173,957 154,650 154,277 1,039,898 675,736 606,677  
Income from operations 12,580 50,091 15,382 26,211 2,248 53,160 20,988 21,781 104,265 98,179 80,503  
Other income (expense)                 3,944 (3,750) 1,077  
Net income (883) $ 23,897 $ 11,277 $ 11,450 (18,152) $ (5,229) $ 56,269 $ 13,167 45,741 46,055 122,083  
LaSalle Medical Associates                        
Assets                        
Cash and cash equivalents 15,671       6,619       15,671 6,619    
Receivables, net 5,064       2,269       5,064 2,269    
Prepaid assets 5,032       0       5,032 0    
Loans receivable 2,250       2,250       2,250 2,250    
Restricted cash 700       696       700 696    
Total assets 28,717       11,834       28,717 11,834    
Liabilities and stockholders’ deficit                        
Current liabilities 30,331       32,405       30,331 32,405    
Stockholders’ deficit (1,614)       (20,571)       (1,614) (20,571)    
Total liabilities, mezzanine equity, and stockholders’ equity $ 28,717       $ 11,834       28,717 11,834    
Statements of Operations                        
Revenues                 253,469 204,061 186,964  
Expenses                 239,884 220,132 185,724  
Income from operations                 13,585 (16,071) 1,240  
Other income (expense)                 (44) 0 8  
Net income                 $ 13,541 $ (16,071) $ 1,248  
[1] The Company’s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $523.7 million and $580.9 million as of December 31, 2022 and December 31, 2021, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $131.8 million and $94.8 million as of December 31, 2022 and December 31, 2021, respectively. These VIE balances do not include $304.8 million of investment in affiliates and $30.3 million of amounts due from affiliates as of December 31, 2022 and $802.8 million of investment in affiliates and $6.6 million of amounts due from affiliates as of December 31, 2021 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 19 – “Variable Interest Entities (VIEs)” for further detail.